Don't get left behind! September 20-21 is the 2nd Annual Endoluminal & Technology Symposium and it's being held in Seoul, South Korea.
For more information and to register, please click here.
Further your expertise and come away from the event with the ability to:
Program details will follow shortly. To register, please click here.
This programme is supported by SIU Corporate Sponsor
Calling all urologists a interested in current trends in the diagnosis and treatment of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED). The upcoming SIU B2B-LUTS & ED Meeting in Greece will cover the hottest topics in LUTS and ED.
If you work i or have a keen interest in these areas, this event is for you. You are guaranteed to learn from the distinguished international experts who will be sharing their knowledge.
For more information and to register, click here.
Don't miss this exciting educational opportunity. Space is limited!
Tremendous advancements have been made in diagnosis and treatment with the recent FDA approval of a targeted therapy for metastatic bladder cancer with FGFR3 or FGFR2 genetic alterations, two combination immunotherapy-targeted therapies as first-line treatment for advanced RCC, as well asadvances in diagnostics and immunotherapy research for prostate cancer
Take advantage of this highly anticipated event and immerse yourself in the evolving landscape of urological cancer care.
For more information and to register, click here. Space is limited!